Stocks to buy: Ashok Leyland, Dr Lal PathLabs among 5 Shares with an upside potential of 39% return
Stocks to buy: Brokerage firms have recommended five stocks that can yield up to 39 per cent.
Stocks to buy: Brokerage firms have recommended five stocks that can yield up to 39 per cent. One may consider the brokerage recommendations for positive yield.
(Disclaimer: The advice given here to invest in stocks is given by a brokerage house. These are not the views of Zee Business. Consult your advisor before investing.)
Metropolis Healthcare
Metropolis Healthcare
Brokerage firm BNP Paribas has recommended Metropolis Healthcare for a price target of Rs 2052. On November 29, 2022, the stock settled at Rs 1,476. Investors can get a return of Rs 576 per share or 39 per cent. Pic: Reuters
Dr. Lal PathLabs
Dr. Lal PathLabs
Brokerage firm BNP Paribas has recommended Dr Lal PathLabs for a price target of Rs 2952. On November 29, 2022, the stock settled at Rs 2,415. Investors can get a return of Rs 537 per share or about 22 per cent. Pic: Pixabay
Blue Star
Blue Star
Brokerage firm AnandRathi has recommended Blue Star for a price target of Rs 1,517. On November 29, 2022, the stock settled at Rs 1,225. Investors can get a return of Rs 292 per share or about 24 per cent. Pic: Pixabay
Ashok Leyland
Ashok Leyland
Brokerage firm ICICI Securities has recommended Ashok Leyland for a price target of Rs 180. On November 29, 2022, the stock settled at Rs 148. Investors can get a return of Rs 32 per share or about 22 per cent. Pic: Pixabay
Cyient
Cyient
Brokerage firm AnandRathi has recommended Cyient for a price target of Rs 1030. On November 29, 2022, the stock settled at Rs 827. Investors can get a return of Rs 203 per share or about 24 per cent. Pic: Pixabay